Australia and New Zealand Adult Extracorporeal Membrane Oxygenation (ECMO) Audit 2005

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00157144
Recruitment Status : Completed
First Posted : September 12, 2005
Last Update Posted : March 10, 2014
Information provided by (Responsible Party):
Bayside Health

Brief Summary:

Extracorporeal membrane oxygenation (ECMO) is a means of artificially performing the function of the human lung and/or heart outside the body. Its use is escalating in a wide range of clinical settings in the adult population without evidence or guidelines to support this practice.

This study involves a nationwide questionnaire which has two components. The initial pilot survey will attempt to identify all institutions currently practicing ECMO or those intending to do so in the future, and are willing to participate in prospective data collection. The second phase will involve a monthly survey of these centres regarding the extent of ECMO use, practice details implemented, and outcome data.

It is hoped that the collection of this information will later assist in the development of guidelines for this expensive and presently unsubstantiated practice, together with the construction of appropriate training programs for staff.

Condition or disease
Respiratory Distress Syndrome, Adult Respiratory Insufficiency Shock, Cardiogenic

Study Type : Observational
Time Perspective: Retrospective
Study Start Date : October 2004
Actual Primary Completion Date : August 2006
Actual Study Completion Date : August 2006

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   16 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients receiving ECMO in Australia and New Zealand

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00157144

Australia, Victoria
Alfred Hospital
Melbourne, Victoria, Australia, 3004
Sponsors and Collaborators
Bayside Health
Principal Investigator: Vincent A Pellegrino, MBBS National Health and Medical Research Council, Australia

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Bayside Health Identifier: NCT00157144     History of Changes
Other Study ID Numbers: 186/04
First Posted: September 12, 2005    Key Record Dates
Last Update Posted: March 10, 2014
Last Verified: March 2014

Keywords provided by Bayside Health:
Lung Transplantation
Heart Transplantation

Additional relevant MeSH terms:
Respiratory Distress Syndrome, Newborn
Respiratory Distress Syndrome, Adult
Respiratory Insufficiency
Pulmonary Valve Insufficiency
Acute Lung Injury
Shock, Cardiogenic
Lung Diseases
Respiratory Tract Diseases
Respiration Disorders
Infant, Premature, Diseases
Infant, Newborn, Diseases
Heart Valve Diseases
Heart Diseases
Cardiovascular Diseases
Lung Injury
Myocardial Infarction
Myocardial Ischemia
Vascular Diseases
Pathologic Processes